Construction of the antisense eukaryotic vector for proliferating cell nuclear antigen gene and its expression in bladder cancer EJ cell line

Qiangsong Tong , Fuqing Zeng , Yipeng Qi , Zhaohui Zhu , Gongcheng Lu

Current Medical Science ›› 2002, Vol. 22 ›› Issue (4) : 327 -330.

PDF
Current Medical Science ›› 2002, Vol. 22 ›› Issue (4) : 327 -330. DOI: 10.1007/BF02896777
Article

Construction of the antisense eukaryotic vector for proliferating cell nuclear antigen gene and its expression in bladder cancer EJ cell line

Author information +
History +
PDF

Abstract

To explore a novel strategy for antisense gene therapy of cancer, the coding sequence of human proliferating cell nuclear antigen (PCNA) cDNA was reversely inserted into the eukaryotic vector pLXSN by molecular cloning techniques and transferred into bladder cancer EJ cells with liposome. The PCNA expression in transferred cells was dynamically detected by immunofluorescence and RT-PCR techniques. Changes of proliferation activities of cancer cells were assayed by MTT colorimetric and cloning formation methods. In the experiment, the antisense eukaryotic vector was successfully constructed and named as pLAPSN. After transfection with it for 1–7 days, PCNA protein and mRNA levels in cancer cells were blocked by 16.74 % – 84.21 % (P<0.05) and 23.27 % – 86.15 % (P<0.05) respectively. The proliferation activities of transferred cells were inhibited by 27.91 % – 62.07 % (P<0.01), with cloning formation abilities being decreased by 50.81% (P<0.01). It was concluded that thein vitro proliferation activities of cancer cells could be effectively inhibited by blocking PCNA expression with antisense technique, which could serve as an ideal strategy for gene therapy of bladder cancer.

Keywords

proliferating cell nuclear antigen / antisense RNA / molecular cloning / gene expression

Cite this article

Download citation ▾
Qiangsong Tong, Fuqing Zeng, Yipeng Qi, Zhaohui Zhu, Gongcheng Lu. Construction of the antisense eukaryotic vector for proliferating cell nuclear antigen gene and its expression in bladder cancer EJ cell line. Current Medical Science, 2002, 22(4): 327-330 DOI:10.1007/BF02896777

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

ZdunekM, KorobowiczE. Expression of PCNA in non-small cell lung cancer before and after treatment with cisplatin and vepeside. Pol J Pathol, 2000, 51(2): 77-77

[2]

1992. 212252

[3]

ZengF Q, ZhuZ H, LinC, et al. . Experimental study of the blocking proliferation effects on human bladder cancer EJ cell line by antisense oligodeoxynucleotide targeting PCNA. Chin J Urol, 2000, 21(4): 213-213

[4]

2000, 20(2): 55

[5]

JeziorskiA, BlonskiJ Z, NiewiadomskaH. The expression of products of oncogens c-erbB2 and EGFR and proliferating antigens Ki67 and PCNA in primary invasive ductal cancer of female breast. J Exp Clin Cancer Res, 2000, 19(1): 61-61

[6]

SakakuraC, HagiwaraA, TsujimotoH, et al. . Inhibition of gastric cancer cell proliferation by antisense oligonucleotides targeting the messenger RNA encoding proliferating cell nuclear antigen. Br J Cancer, 1994, 70: 1060-1060

AI Summary AI Mindmap
PDF

81

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/